SCHEMBL31491271

SCHEMBL31491271

Cc1noc(-c2ccc(-c3nc4c(c(NC5CCC(O)CC5)n3)[S@+]([O-])CC4)cc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 3/20 0.39
▸ ADORA2A P29274 2/20 0.39
▸ ADORA3 P0DMS8 1/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ PIK3CD O00329 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ IRAK4 Q9NWZ3 1/20 0.34
▸ OPRK1 P41145 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ KCNH2 Q12809 5/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ GPR119 Q8TDV5 1/20 0.31
▸ ACP1 P24666 1/20 0.31
▸ TSHR P16473 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31491391 0.85 ADORA1 (0.39) ADORA1ADORA2AADORA3ADORA2BACP1
SCHEMBL31491291 0.82 ADORA2A (0.37) ADORA1ADORA2AADORA3ADORA2BACP1
SCHEMBL31491323 0.76 LATS1 (0.38) PIK3CDPIK3CBPIK3CGLMNATHRB
SCHEMBL31491311 0.74 LTA4H (0.33) —
SCHEMBL31491337 0.72 PRKCI (0.34) MAPK1
SCHEMBL31474619 0.71 ADORA3 (0.32) ADORA1ADORA2AADORA3ADORA2B
SCHEMBL31474601 0.69 S1PR5 (0.32) —
SCHEMBL31491287 0.68 LTA4H (0.33) —
SCHEMBL31491300 0.67 LTA4H (0.33) —
SCHEMBL10283145 0.66 PIK3CA (0.36) PIK3CDPIK3CBPIK3CGIRAK4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025067168-A1 AZA FUSED RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 苏州爱科百发生物医药技术有限公司 2025-04-03 — — WO disclosed
Send feedback